Skip to main content

Astrana Health, Inc.

corporate_fare Company Profile

Astrana Health, Inc.

ASTH·NASDAQ·Trade & Services·CIK 0001083446

Astrana is a physician-centric, technology-powered healthcare company that operates an integrated healthcare delivery platform. The company enables providers to participate in value-based care arrangements, helping them deliver accessible, high-quality, and cost-effective care. Astrana, along with its affiliated physician groups, consolidated subsidiaries, and VIEs, provides coordinated outcome-based care to patients covered by private or public insurance, including Medicare, Medicaid, and HMOs, with a small portion of revenue from non-insured patients. Astrana offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians, physician and specialist extenders, and hospitalists. As of December 31, 2025, Astrana’s integrated health network comprised more than 20,000 contracted physicians and was responsible for coordinating value-based care for approximately 1.6 million patients. The company operates through three reportable segments: Care Partners, Care Delivery, and Care Enablement. The Care Partners segment focuses on building and managing high-quality provider networks by partnering with and investing in provider partners to achieve coordinated care delivery. Astrana's common stock is listed on The Nasdaq Stock Market LLC under the symbol "ASTH."

Astrana Health, Inc. (NASDAQ:ASTH) is a publicly traded company in the Trade & Services sector. Wiseek monitors ASTH SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Shareholders Approve 1 Million Share Increase for Equity Incentive Plan
  • Astrana Health Reports Robust Q1 2026 Results with 56% Revenue Growth and Doubled Net Income
  • Astrana Health Projects Q2 Revenue Between $965M and $1B
  • Astrana Health Reports Strong Q1 2026 Results with 56% Revenue Growth and Reaffirms Full-Year Guidance
  • Astrana Health Seeks Shareholder Approval for 1 Million Share Increase in Equity Incentive Plan

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$3.18B
Net Income
$22.49M
Diluted EPS
$0.46
Op. Cash Flow
$114.6M
Free Cash Flow
$104.49M
Operating Income
$78.53M
Cash & Equivalents
$429.47M
Total Debt
$1.04B
Debt / Equity
1.33×
Net Margin
0.7%
Shares Outstanding
48.89M sh
Source: 10-K · filed 2026-03-12 · accession 0001193125-26-103128
Browse all tickers starting with A →
$38.62
52-week range · as of 2026-06-10 $18.08 – $39.93
Market cap
$1.91B
Volume
520K (1.0× avg)
3-mo avg 496.7K
Live data · 2026-06-14 06:07 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ASTH - Latest Insights

ASTH
Jun 10, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $38.73
Real-time Price: $38.62 info
Change: -$0.110 (-0.28%) info
Market Cap: $1.915B info
ASTH
May 08, 2026, 6:01 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $35.21
Real-time Price: $38.62 info
Change: +$3.41 (+10%) info
Market Cap: $1.915B info
ASTH
May 07, 2026, 4:27 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $33.00
Real-time Price: $38.62 info
Change: +$5.62 (+17%) info
Market Cap: $1.915B info
ASTH
May 07, 2026, 4:12 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $35.00
Real-time Price: $38.62 info
Change: +$3.62 (+10%) info
Market Cap: $1.915B info
ASTH
Apr 17, 2026, 6:01 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $30.60
Real-time Price: $38.62 info
Change: +$8.02 (+26%) info
Market Cap: $1.915B info
ASTH
Mar 30, 2026, 7:39 PM EDT
Filing Type: S-3ASR
Importance Score:
7
Price at Filing: $24.25
Real-time Price: $38.62 info
Change: +$14.37 (+59%) info
Market Cap: $1.915B info
ASTH
Mar 30, 2026, 5:43 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $24.34
Real-time Price: $38.62 info
Change: +$14.28 (+59%) info
Market Cap: $1.915B info
ASTH
Mar 12, 2026, 8:11 AM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $23.91
Real-time Price: $38.62 info
Change: +$14.71 (+62%) info
Market Cap: $1.915B info
ASTH
Mar 02, 2026, 7:11 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $21.50
Real-time Price: $38.62 info
Change: +$17.12 (+80%) info
Market Cap: $1.915B info
ASTH
Jan 12, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $29.21
Real-time Price: $38.62 info
Change: +$9.41 (+32%) info
Market Cap: $1.915B info